MedTrace Logo

A Study to Evaluate the Effect of Astaxanthin in Healthy Participants

NCT05376501 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-12-01

No results posted yet for this study

Summary

Astaxanthin is recognized as a bioactive compound with potential benefits for human health. This study aims to evaluate a specific nutritional supplement impact on markers of oxidative stress, inflammation, lipid levels, blood flow, visual skin markers, measures of longevity, mood and skin condition.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Astaxanthin

8 mg Astaxanthin per capsule, taken once a day with meal

OTHER

Placebo

Modified food starch

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • LycoRed Ltd.

    lead INDUSTRY

Principal Investigators

  • Shoná Burkes-Henderson, PhD · SGS Stephens, Inc

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2022-10-01
Completion
2022-10-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05376501 on ClinicalTrials.gov